Internal Medicine · East Orange, NJ
NPI
1962476903
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
9
Medicare group memberships
Hospitals
2
Hospital affiliations
613 Park Ave
East Orange, NJ, 07017
Phone (973) 672-8573
Groups this clinician bills Medicare through
Medicare paid, 2024
$770K
12,175 services
Medicare patients, 2024
812
Average age 70
Drug cost, 2024
$2.8M
9,708 prescriptions
Company payments, 2025
$27K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alexander G Salerno was code 99214 (office e&m - established), 1,034 times for 417 patients. In total Alexander G Salerno billed 12,175 services in 116 codes, and Medicare paid $770K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,034 | 417 | $99.09 | $102K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 952 | 297 | $41.41 | $39K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 932 | 380 | $52.47 | $49K |
| 99213 Office E&M - Established | Office | 563 | 323 | $72.47 | $41K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 545 | 294 | $13.36 | $7,282 |
| 99212 Office E&M - Established | Office | 518 | 241 | $45.29 | $23K |
| 99308 SNF E&M | Office | 438 | 19 | $63.61 | $28K |
| 99483 Office/Outpatient Services | Office | 438 | 349 | $227.08 | $99K |
| 99232 Hospital E&M - Subsequent | Facility | 346 | 67 | $65.36 | $23K |
| 82962 Clinical Chemistry | Office | 299 | 156 | $3.21 | $960 |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 272 | 100 | $62.57 | $17K |
| 94060 Pulmonary Function Testing | Office | 196 | 164 | $34.26 | $6,715 |
| 94729 Pulmonary Function Testing | Office | 196 | 164 | $50.96 | $9,988 |
| 94727 Pulmonary Function Testing | Office | 196 | 164 | $39.50 | $7,742 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 183 | 183 | $21.00 | $3,842 |
By year: 2022 $488K for 7,807 services; 2023 $570K for 8,743 services; 2024 $770K for 12,175 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 299 | 156 | $3.21 | $960 |
| 87428 Infectious Agent Detection by DNA/RNA | 43 | 38 | $68.88 | $2,962 |
| 36415 Venipuncture Blood Collection | 34 | 29 | $8.65 | $294 |
| 87807 Immunoassay | 13 | 12 | $11.65 | $152 |
Medicare prescription drug claims, 2024
In 2024, the drug Alexander G Salerno prescribed most often to Medicare patients was Rosuvastatin Calcium, with 408 prescriptions and refills. In total Alexander G Salerno wrote 9,708 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 408 | 929 | 182 | $8,344 |
| Atorvastatin Calcium Generic | 388 | 802 | 182 | $4,613 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 241 | 292 | 81 | $6,186 |
| Eliquis Apixaban | 216 | 293 | 63 | $156K |
| Qutenza Capsaicin/Skin Cleanser | 208 | 620 | 141 | $733K |
| Amlodipine Besylate Generic | 206 | 410 | 96 | $1,382 |
| Jardiance Empagliflozin | 206 | 319 | 84 | $183K |
| Repatha Sureclick Evolocumab | 181 | 228 | 61 | $127K |
| Carvedilol Generic | 177 | 329 | 72 | $1,256 |
| Levothyroxine Sodium Generic | 170 | 344 | 67 | $1,380 |
| Olmesartan Medoxomil Generic | 168 | 374 | 77 | $6,372 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 166 | 180 | 59 | $114K |
| Metoprolol Succinate Generic | 166 | 317 | 70 | $2,408 |
| Omega-3 Acid Ethyl Esters Generic | 154 | 299 | 68 | $12K |
| Gabapentin Generic | 142 | 184 | 66 | $1,316 |
Brand drugs: 2,785 claims; generic drugs: 6,750 claims; opioid claims: 57.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alexander G Salerno $27K ($27K in general payments such as food, travel and fees) from 10 companies. The largest payer was AngioDynamics, Inc. with $27K.
| Company | Payments | Amount |
|---|---|---|
| AngioDynamics, Inc. ANGO | 6 | $27K |
| Madrigal Pharmaceuticals MDGL | 2 | $124 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $36.73 |
| Hologic Sales and Service, LLC HOLX | 1 | $27.66 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $25.38 |
| Novo Nordisk Inc NVO | 1 | $24.24 |
| Dexcom, Inc. DXCM | 1 | $20.13 |
| Amgen Inc. AMGN | 1 | $19 |
| Averitas Pharma Inc. | 1 | $16.32 |
| Pfizer Inc. PFE | 1 | $14.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.